Titre du document / Document title
Metabolic factors affecting residual beta cell function assessed by C-peptide secretion in patients with newly diagnosed type 1 diabetes
Auteur(s) / Author(s)
IMDIAB Group, ITALIE
PICARDI A. ;
VISALLI N. ;
LAURIA A. ;
SURACI C. ;
BUZZETTI R. ;
MEROLA M. K. ;
MANFRINI S. ;
GUGLIELMI C. ;
GENTILUCCI U. V. ;
PITOCCO D. ;
CRINO A. ;
BIZZARRI C. ;
CAPPA M. ;
POZZILLI P. ;
Affiliation(s) du ou des auteurs / Author(s) Affiliation(s)
Résumé / Abstract
Background: In recent onset of type 1 diabetes, the residual beta cell function, assessed by baseline and/or stimulated C-peptide secretion, can be a useful parameter to establish the extension of beta cell destruction. How metabolic parameters at diagnosis influence residual C-peptide secretion is not well established. Patients and Methods: We analyzed 553 consecutive patients with recent onset (< 4 weeks) of type 1 diabetes (250 females and 303 males, mean age 15 ± 8 years). Baseline and stimulated C-peptide by i.v. glucagon were evaluated using a highly sensitive radio-immunoassay. Metabolic parameters including blood glucose, HbA1c, insulin dose, and BMI were also evaluated. Results: Baseline and stimulated C-peptide were 0.26±0.22 and 0.47±0.38 nmol/l and correlated positively with age (p < 0.001). There was no significant correlation between C-peptide and blood glucose at diagnosis. BMI was positively correlated with both baseline and stimulated C-peptide secretion (p<0.001). By contrast, HbA1c levels inversely correlated with both baseline and stimulated C-peptide secretion (p<0.001). Conclusion: In type 1 diabetes at diagnosis, baseline and stimulated C-peptide are higher in pubertal and young adult patients compared with pre-pubertal patients suggesting that such parameter can be used as an end point marker for studies aimed at protecting and/or restoring beta cells in patients with substantial beta cell function. High levels of HbA1c and lower BMI are dependent variables of C-peptide values.
Revue / Journal Title
Hormone and metabolic research
ISSN 0018-5043
CODEN HMMRA2
Source / Source
2006, vol. 38, n
o10, pp. 668-672 [5 page(s) (article)]
Langue / Language
Anglais
Editeur / Publisher
Thieme, Stuttgart, ALLEMAGNE
(1969)
(Revue)
Mots-clés d'auteur / Author Keywords
Baseline and stimulated C-peptide, type 1 diabetes ;
HbA1c ;
insulin dose ;
Localisation / Location
INIST-CNRS, Cote INIST : 14356, 35400014306436.0080
Nº notice refdoc (ud4) : 18252889